Caisse d'Epargne Rhone Alpes
VC Fund
Lyon, France
Caisse d'Epargne Rhone Alpes is a cooperative bank that supports all economic players.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries Caisse d'Epargne Rhone Alpes invests in
Stages Caisse d'Epargne Rhone Alpes invests in
Countries Caisse d'Epargne Rhone Alpes invests in
Investment Focus
Industry
- Advice 1 (20%)
- Battery 1 (20%)
- Medical 1 (20%)
- Hardware 1 (20%)
- Industrial 1 (20%)
Stage
- Debt Financing 3 (60%)
- Series A 1 (20%)
- Venture - Series Unknown 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Ventuno Biotech
|
Ventuno Biotech is a biotech company that is developing innovative cancer therapies. | $1.2M / Debt Financing / Nov 26, 2025 | |
Verkor
|
Verkor is a battery cell manufacturer whose goal is to increase the production of low-carbon batteries to fulfill the growing demand for electric vehicles. The company focuses on the development of low-carbon batteries with a carbon footprint that is many times smaller than standard batteries. This reduces the logistics footprint, includingemissions, and provides businesses with batteries that are very inexpensive and use carbon-free electricity. | $1.4B / Debt Financing / May 24, 2024 | |
B2eBike
|
B2ebike provides comprehensive electric bicycle fleet (VAE) solutions for businesses and communities. The best strategy to convert to a soft form of transportation. | $1.9M / Venture - Series Unknown / Jan 04, 2024 | |
SiPearl
|
SiPearl is the French semiconductor company designing the high-performance, low-power microprocessor for exascale supercomputers. It will commercialize Rhea, its first range of microprocessor, early 2024 based on a roadmap closely aligned with the European Union’s goals. Rhea is based on Arm Neoverse V1 architecture. SiPearl has already committedto producing it using N6 or better processes from TSMC.The company was founded in 2019 and headquartered in Maisons-Laffitte, Île-de-France with R&D centers in France (Grenoble, Maisons-Laffitte, Massy, Sophia Antipolis), Germany (Duisburg) and Spain (Barcelona). | $8.8M / Debt Financing / Dec 30, 2023 | |
Remedee Labs
|
1.5 billion people worldwide suffer from chronic pain and over half of them are not satisfied with their care. Remedee Labs aims to give these patients a new life. Based on 10 years of pre-clinical and clinical research, Remedee Labs has developed the first endorphin stimulator for personal use. Building on the experience of its clinicalpartners, the company now uses its unique technology to offer the first patient-centered digital service platform for chronic pain management, working alongside medical practitioners. Remedee Labs initial focus is helping patients with fibromyalgia, and plans extend the Platform offering to other chronic pain conditions in the coming future.Founded in 2016, Remedee Labs announced in 2019 that it had raised 12 million dollard from investors, including HCVC, Habert Dassault Finance, Partech, Supernova Invest and C4 Venture. | $12.8M / Series A / Dec 06, 2022 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Caisse d'Epargne Rhone Alpes invest in?
Caisse d'Epargne Rhone Alpes invests primarily in Advice, Battery and Medical startups, most often at Debt Financing and Series A stage. Most of the 5 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Caisse d'Epargne Rhone Alpes last invest?
The most recent investment recorded for Caisse d'Epargne Rhone Alpes closed in Nov 2025. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
